BriaCell Therapeutics Corp. carries a market capitalization of 9.96M, placing it among publicly traded companies globally.
| Market Cap | 9.96M |
| Enterprise Value | N/A |
BriaCell Therapeutics Corp.'s stock has gained approximately 20.9209% over the past 52 weeks. The 50-day moving average sits at 1.00, while the 200-day moving average is 1.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 20.9209% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.00 |
| Average Volume (20 Days) | N/A |